吲哚菁绿荧光显影导航技术在肝胆外科手术中的应用进展

doi:10.3969/j.issn.1009-976X.2022.04.001

岭南现代临床外科 ›› 2022, Vol. 22 ›› Issue (04): 315-321.DOI: 10.3969/j.issn.1009-976X.2022.04.001

• 述评 • 下一篇

吲哚菁绿荧光显影导航技术在肝胆外科手术中的应用进展

蔡上林, 王博^#, 李坚^*

中山大学附属第五医院肝胆外科, 广东珠海 519000

通讯作者: *李坚, Email:lijian5@mail.sysu.edu.cn。
#并列第一作者
作者简介:李坚,主任医师, 博士生导师, FACS。目前担任中山大学附属第五医院普外科主任、肝胆外科及肝移植科主任。临床工作主要从事肝胆外科及肝移植, 擅长消化道肿瘤（肝癌、肠癌肝转移、胆管癌、胰腺癌等）的外科（微创、荧光显影导航）手术及综合诊治;对肝移植手术及围手术期管理有丰富经验。承担国家级及省级科研项目14项。任广东省医学会肝胆胰外科分会常务委员;珠海市医师协会肝胆胰外科分会主任委员;珠海市医师协会普外分会副主任委员;珠海市抗癌协会消化道肿瘤专委会主任委员;中国医院协会器官获取与分配工作委员会第二届委员会委员;国际肝胆胰协会中国分会肝胆胰外科ERAS专业委员会委员。获“岭南名医”, “广东省杰出青年医学人才”等荣誉称号。
基金资助:
广东省自然科学基金（2022A1515011244）

Application and progress of indocyanine green fluorescence imaging navigation technology in hepatobiliary surgery

CAI Shang-lin^#, WANG Bo^#, LI Jian

Department of Hepatobiliary Surgery, the Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong 519000, China

Online:2022-08-20 Published:2022-09-22
Contact: LI Jian, lijian5@mail.sysu.edu.cn.
# These authors shared first authorship and contributed equally to this work

摘要/Abstract

摘要： 吲哚菁绿荧光显影已经广泛地应用于肝胆外科手术中, 在原发性肝癌、肠癌肝转移、肝胆管结石、肝移植等良恶性肝胆外科手术中, 其能够提高手术效能, 改善手术患者的预后。笔者通过复习相关的国内外研究进展, 结合ICG导航技术在肝胆外科常见疾病手术中的应用进行相应的总结, 并作进一步的探讨和展望。

关键词: 吲哚菁绿, 荧光显影, 手术切除

Abstract: Indocyanine green fluorescence imaging has been widely utilized in hepatobiliary surgery, including primary liver cancer, colorectal liver metastasis, liver transplantation, hepatolithiasis as well as other benign and malignant diseases of the liver. It has been proven that it can enhance the effect of surgical resection and improve the prognosis for patients undergoing surgery. By reviewing relevant research progress, the author summarizes the application of ICG imaging navigation technology in hepatobiliary surgery. Finally, the author makes further discussion and speculates on the development of the technology.

Key words: indocyanine green, fluorescence imaging, surgery

中图分类号:

R656

蔡上林, 王博, 李坚. 吲哚菁绿荧光显影导航技术在肝胆外科手术中的应用进展[J]. 岭南现代临床外科, 2022, 22(04): 315-321.

CAI Shang-lin, WANG Bo, LI Jian. Application and progress of indocyanine green fluorescence imaging navigation technology in hepatobiliary surgery[J]. Lingnan Modern Clinics In Surgery, 2022, 22(04): 315-321.

参考文献

[1] Kochubey VI, Kulyabina TV, Tuchin VV, et al.Spectral characteristics of indocyanine Green upon its interaction with biological tissues[J]. Opt Spectrosc, 2005, 99(4):560-566.
[2] Hauptmann J, Jrg Stürzebecher.Influence of Indocyanine Green on Plasma Disappearance and Biliary Excretion of a Synthetic Thrombin Inhibitor of the 3-Amidinophenyl-alanine Piperazide-type in Rats[J]. Pharm Res, 1998, 15(5):751-754.
[3] Yoneya S.Binding properties of indocyanine green in human blood[J]. Invest Ophthalmol Vis, 1998, 39.
[4] Ishizawa T, Fukushima N, Shibahara J, et al.Real-time identification of liver cancers by using indocyanine green fluorescent imaging[J]. Cancer, 2009, 115(11):2491-2504.
[5] Ishizawa T, Zuker NB, Kokudo N, et al.Positive and negative staining of hepatic segments by use of fluorescent imaging techniques during laparoscopic hepatectomy[J]. Arch Surg, 2012, 147(4):393-394.
[6] Zhang Z, He K, Chi C, et al.Intraoperative fluorescence molecular imaging accelerates the coming of precision surgery in China[J]. Eur J Nucl Med Mol Imaging, 2022, 49(8):2531-2543.
[7] 中华医学会数字医学分会, 中国医师协会肝癌专业委员会, 中国医师协会精准医学专业委员会, 等. 吲哚菁绿分子荧光影像技术诊断原发性肝癌与术中导航操作诊疗规范(2021版)[J]. 中国实用外科杂志, 2021, 41(9):1002-1013.
[8] Zhang YM, Shi R, Hou JC, et al.Liver tumor boundaries identified intraoperatively using real-time indocyanine green fluorescence imaging[J]. J Cancer Res Clin Oncol, 2017, 143(1):51-58.
[9] Hasegawa K, Kokudo N, Imamura H, et al.Prognostic impact of anatomic resection for hepatocellular carcinoma[J]. Ann Surg, 2005, 242(2):252-259.
[10] Hidaka M, Eguchi S, Okuda K, et al.Impact of Anatomical Resection for Hepatocellular Carcinoma With Microportal Invasion (vp1):A Multi-institutional Study by the Kyushu Study Group of Liver Surgery[J]. Ann Surg, 2020, 271(2):339-346.
[11] Inoue Y, Arita J, Sakamoto T, et al.Anatomical Liver Resections Guided by 3-Dimensional Parenchymal Staining Using Fusion Indocyanine Green Fluorescence Imaging[J]. Ann Surg, 2015, 262(1):105-111.
[12] Aoki T, Murakami M, Yasuda D, et al.Intraoperative fluorescent imaging using indocyanine green for liver mapping and cholangiography[J]. J Hepatobiliary Pancreat Sci, 2010, 17(5):590-594.
[13] Takasaki K.Glissonean pedicle transection method for hepatic resection:a new concept of liver segmentation[J]. J Hepatobiliary Pancreat Sci, 1998, 5(3):286-291.
[14] Cho A, Okazumi S, Makino H, et al.Relation between Hepatic and Portal Veins in the Right Paramedian Sector:Proposal for Anatomical Reclassification of the Liver[J]. World J Surg, 2004, 28(1):8-12.
[15] Wang HQ, Yang J, Yang JY, et al.Bile leakage test in liver resection:A systematic review and meta-analysis[J]. World J Gastroenterol, 2013, 19(45):8420-8426.
[16] Kaibori M, Ishizaki M, Matsui K, et al.Intraoperative indocyanine green fluorescent imaging for prevention of bile leakage after hepatic resection[J]. Surgery, 2010, 150(1):91.
[17] 谢国伟, 李嘉鑫, 吴泓. 吲哚氰绿荧光显像导航技术在复发性肝癌腹腔镜再次肝切除中的应用[J]. 中华肝脏外科手术学电子杂志, 2020, 9(2):153-157.
[18] 邹雄峰, 简志祥. 吲哚菁绿荧光成像在复发性肝癌手术治疗中的应用[J].中国实用外科杂志, 2019, 39(10):1040-1041.
[19] Peloso A, Franchi E, Canepa MC, et al.Combined use of intraoperative ultrasound and indocyanine green fluorescence imaging to detect liver metastases from colorectal cancer[J]. HPB (Oxford), 2013, 15(12):928-934.
[20] Mise Y, Aloia TA, Brudvik KW, et al.Parenchymal-sparing Hepatectomy in Colorectal Liver Metastasis Improves Salvageability and Survival[J]. Ann Surg, 2016, 263(1):146-152.
[21] He K, Hong X, Chi C, et al.Efficacy of Near-Infrared Fluorescence-Guided Hepatectomy for the Detection of Colorectal Liver Metastases:A Randomized Controlled Trial[J]. J Am Coll Surg, 2022, 234(2):130-137.
[22] Norton JA.Enhanced Operative Detection of Colorectal Liver Metastases[J]. J Am Coll Surg, 2022, 234(2):138.
[23] Schols RM, Bouvy ND, Masclee AAM, et al.Fluorescence cholangiography during laparoscopic cholecystectomy:a feasibility study on early biliary tract delineation[J]. Surg Endosc, 2013, 27(5):1530-6.
[24] Kaneko J, Ishizawa T, Masuda K, et al.Indocyanine green reinjection technique for use in fluorescent angiography concomitant with cholangiography during laparoscopic cholecystectomy[J]. Surg Laparosc Endosc Percutan Tech, 2012, 22(4):341.
[25] He K, Hong X, Chi C, et al.A new method of near-infrared fluorescence image-guided hepatectomy for patients with hepatolithiasis:a randomized controlled trial[J]. Surg Endosc, 2020, 34(11):4975-4982.
[26] Ren J, Yuan C, Zhang T.Indocyanine green fluorescence imaging:A novel technique in liver transplantation[J]. Liver Res, 2021, 5:204-208.
[27] Coubeau L, Frezin J, Dehon R, et al.Indocyanine green fluoroscopy and liver transplantation:a new technique for the intraoperative assessment of bile duct vascularization[J]. Hepatobiliary Pancreat Dis Int, 2017, 16(4):440-442.
[28] Dousse D, Vibert E, Nicolas Q, et al.Indocyanine Green Fluorescence Imaging to Predict Graft Survival After Orthotopic Liver Transplantation:A Pilot Study[J]. Liver Transpl, 2020, 26(10):1263-1274.
[29] Hernot S, van Manen L, Debie P, et al. Latest developments in molecular tracers for fluorescence image-guided cancer surgery[J]. Lancet Oncol, 2019, 20(7):e354-e367.
[30] Zhang Y, Zhang Y, Zhu J, et al.Clinical application of indocyanine green fluorescence imaging in laparoscopic lymph node dissection for intrahepatic cholangiocarcinoma:A pilot study (with video)[J]. Surgery, 2022, 171(6):1589-1595.
[31] Wang X, Teh CSC, Ishizawa T, et al.Consensus Guidelines for the Use of Fluorescence Imaging in Hepatobiliary Surgery[J]. Ann Surg, 2021, 274(1):97-106.
[32] Hu Z, Fang C, Li B, et al.First-in-human liver-tumour surgery guided by multispectral fluorescence imaging in the visible and near-infrared-I/II windows[J]. Nat Biomed Eng, 2020, 4(3):259-271.
[33] Marino MV, Podda M, Fernandez CC, et al.The application of indocyanine green-fluorescence imaging during robotic-assisted liver resection for malignant tumors:a single-arm feasibility cohort study[J]. HPB (Oxford), 2020, 22(3):422-431.
[34] Garrido A, Djouder N.Cirrhosis:A Questioned Risk Factor for Hepatocellular Carcinoma[J]. Trends Cancer, 2021, 7(1):29-36.
[35] Kanwal F, Singal AG.Surveillance for Hepatocellular Carcinoma:Current Best Practice and Future Direction[J]. Gastroenterology, 2019, 157(1):54-64.
[36] Hoogstins CES, Boogerd LSF, Sibinga Mulder BG, et al.Image-Guided Surgery in Patients with Pancreatic Cancer:First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent[J]. Ann Surg Oncol, 2018, 25(11):3350-3357.
[37] Lu G, van den Berg NS, Martin BA, et al. Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW:a phase 1 single-centre, open-label, single-arm, dose-escalation study[J]. Lancet Gastroenterol Hepatol, 2020, 5(8):753-764.
[38] Gao RW, Teraphongphom NT, van den Berg NS, et al. Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence[J]. Cancer Res, 2018, 78(17):5144-5154.
[39] de Valk KS, Deken MM, Handgraaf HJM, et al. First-in-Human Assessment of cRGD-ZW800-1, a Zwitterionic, Integrin-Targeted, Near-Infrared Fluorescent Peptide in Colon Carcinoma[J]. Clin Cancer Res, 2020, 26(15):3990-3998.

吲哚菁绿荧光显影导航技术在肝胆外科手术中的应用进展

Application and progress of indocyanine green fluorescence imaging navigation technology in hepatobiliary surgery

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 4

编辑推荐

Metrics

[1]	张桥, 莫阿里, 高恒毅, 周伟, 夏丰, 张伟桥, 陈伟强. 直径不大于5 cm孤立性肝癌：射频消融与手术治疗的比较[J]. 岭南现代临床外科, 2022, 22(04): 328-335.
[2]	龙吟, 宋兴东, 张磊. 中晚期肝癌转化治疗中的几个焦点问题[J]. 岭南现代临床外科, 2022, 22(02): 115-119.
[3]	陈敏强，李文韬，陈念平*. 非侵入吲哚菁绿试验在肝脏外科的临床应用[J]. 岭南现代临床外科, 2019, 19(06): 771-775.
[4]	何嘉辉彭水清. 腕部腱鞘囊肿抽吸注药与手术切除对比分析[J]. 岭南现代临床外科, 2015, 15(06): 737-739.